
Signios Bio
Signios Biosciences, (formerly named MedGenome US Research) is a multiomics and bioinformatics company dedicated to revealing the intricate signals within biological data. By combining cutting-edge AI, multiomic technologies, and scientific partnership, Signios Bio enables the discovery and development of next-generation therapies and diagnostics that are more inclusive, effective, and transformative.
Latest Content

Industry Insight
Multiomics: A 360° View into Biology and Medicine
Explore how multiomics research combines genomics, proteomics, and transcriptomics to offer new insights in disease modeling and therapeutic advancements.

Product News
Signios Bio Launches With AI-Driven Bioinformatics and Advanced Multiomics Platform
Signios Bio, formerly the US research division of MedGenome, has rebranded to reflect its bold vision in AI-powered bioinformatics and multiomics. With an integrated suite of technologies spanning genomics, proteomics and spatial biology.
Advertisement